Monday, August 11 16:00:15
According to accounts just filed, Beckman Coulter Ireland, the Irish unit of US-owned global pharmaceutical group, posted E4.3m on revenues of just over E190m in the 17 months to the end of December 2012.
The company was established after Beckman Coulter purchased the lab-based diagnostic business of Japanese firm Olympus, which operated a plant in Co Clare.
The main activity of Beckman Coulter is the manufacturing of pharmaceutical preparations for diagnostic reagents, along with research and development of the products manufactured.
The directors' report states that the "results for the year are in line with directors' expectations. These expectations were based on internally-generated budgets and management accounts for the newly-formed legal entity".
The profit takes account of redundancy costs of E2m. Numbers employed total 362.
The accounts show that the firm recorded an operating profit of €8.82m in 2012. Redundancy costs along with net finance and interest costs of E2.4m reduced the firm's profits to E4.3m.